Robert Curtis Mcrae serves as Executive at PALISADE BIO, INC., where they oversee executive responsibilities. Since joining the company, Robert Curtis Mcrae has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 3, 2023 involved exercising options for 655 shares valued at $0.
Robert Curtis Mcrae currently holds 895 shares of PALISADE BIO, INC. (PALI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Curtis Mcrae has been a net neutral trader of PALI stock. They have purchased $0 and sold $0 worth of shares.
Robert Curtis Mcrae's most recent insider trade was on Apr 3, 2023, when they sold 655 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.00 |
| Discretionary |